Cerebellar rTMS for the Treatment of Schizophrenic Patients

Completed · Not applicable

Conditions studied: Schizophrenia

In brief

The primary aim of this protocol is to determine whether the use of repetitive transcranial magnetic stimulation (rTMS) over vermis of the cerebellum may be safe and therapeutically effective in patients with schizophrenia. Because this is the first evaluation of this treatment in this population, the focus of this study is safety.

Key facts

Study ID
NCT01072617
Run by
Beth Israel Deaconess Medical Center
People needed
8
Starts
2008-02-01
Expected to finish
2009-04-01
Last updated by the study team
2017-06-05

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.